| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |